Navigation Links
Established Safety Profile of Spiriva Confirmed by 30 Rigorously Controlled Clinical Trials and the Landmark Trial UPLIFT
Date:9/23/2008

New Data from Landmark UPLIFT Trial Further Supports Spiriva's Safety Profile

RIDGEFIELD, Conn. and NEW YORK, Sept. 23 /PRNewswire/ -- Boehringer Ingelheim and Pfizer Inc have released a new analysis of 30 rigorously controlled clinical trials, including UPLIFT, confirming the long term safety profile of Spiriva(R) HandiHaler(R) (tiotropium bromide inhalation powder). The new and expanded safety data contradicts the conclusions about tiotropium in an article by Singh et al. published in the September 24th issue of the Journal of the American Medical Association.(1) Both companies considered it important to release these data to ensure doctors have the most comprehensive, up-to-date safety information on tiotropium in order to make the best treatment decisions for their patients.

Because COPD (Chronic Obstructive Pulmonary Disease) patients have in general a higher cardiovascular risk than the average population(2), cardiovascular safety in a COPD medication is of critical importance. Therefore Boehringer Ingelheim has put special emphasis on the broad investigation of Spiriva including its cardiovascular safety.

The latest analysis of 30 placebo-controlled double-blind, randomized trials with data from 19,545 COPD patients (tiotropium 10,846, placebo 8,699) conducted by Boehringer Ingelheim demonstrated that there is no increased risk of death (all-cause) or death due to cardiovascular events in patients treated with Spiriva, specifically:

-- No increased risk of total (all-cause) mortality (relative risk ratio

for all cause mortality= 0.88, 95% CI=0.77, 0.999)

-- No increased risk of mortality due to cardiac (relative risk ratio for

mortality due to cardiac events= 0.77, CI = 0.55, 1.03) and vascular

events (relative risk ratio for mortality due to vascular events= 0.44,

95% CI = 0.19, 1.02).

-- No increased risk in stroke (relative risk ratio for stroke = 1.03, 95%


'/>"/>
SOURCE Boehringer Ingelheim; Pfizer Inc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Studies Confirm Safety, Effectiveness of Balloon Sinuplasty(TM) Technology for Chronic Sinusitis
2. Nutrition 21 Reports That National Toxicology Program Studies Support the Safety of Chromium Picolinate
3. 338 Patient Pivotal Trial Demonstrates Safety and Effectiveness of Polidocanol Sclerotherapy Product for Varicose Vein Treatment
4. Catheter Ablation System for Atrial Fibrillation Shows Reduced Procedure Time, Remarkable Safety Profile and Excellent Outcomes in Two Clinical Studies
5. Biosensors DES Demonstrates Equivalent Safety and Efficacy to Industry Leading DES in First Real World, All Comers Clinical Study
6. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
7. FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
8. Secretary Reinforces VAs Commitment to Research Safety and Veteran Focus
9. AlphaDetail AlphaPulse(TM): Most Practicing Physicians React Positively to FDA Panels Recommendation for Additional Cardiovascular Safety Trials for New Diabetes Medications.
10. Studies of an Innovative Catheter Ablation System for Atrial Fibrillation Reveal Excellent Outcomes, Safety Profile and Fast Procedure Times
11. Micromet and Nycomed Begin Formal Preclinical Safety Studies for Antibody MT203 for Inflammatory and Autoimmune Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 About ... in dryness of eyes due to deficient tear production ... This syndrome is of two types: aqueous tear deficient ... deficient dry eye, lacrimal glands do not produce enough ... eye. Meibomian glands secrete lipids to slow tear evaporation ...
(Date:9/3/2015)... , Sept. 3, 2015  As part of its ... heart disease, Marc R. Katz , MD, MPH, ... Secours Heart & Vascular Institute implanted the first HeartMate ... The patient was selected as part of the prestigious ... 60 elite centers in the United States—and the first ...
(Date:9/3/2015)... Sep. 03, 2015 Research ... the "Investigation Report on China,s Trastuzumab Market, 2010-2019" ... Genentech, trastuzumab was approved by FDA to be used ... name of Herceptin, a major product of Roche. In ... billion around the world. After entering ...
Breaking Medicine Technology:Global Dry Eye Syndrome Market 2015-2019 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 2Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 3Bon Secours' Patient FIRST in Central Virginia to receive New Life-saving Care 4Investigation Report on China's Trastuzumab (Genentech) Market, 2010-2019 2
... Sept. 27, 2011 As a result of the ... be dangerous to their health, according to Consumer Reports, ... currently take a prescription medicine told pollsters they,d cut ... visit or medical procedure, declining tests, or ordering cheaper ...
... WASHINGTON, Sept. 27, 2011 More than 60 medical ... the globe will present their technologies at AdvaMed ... diagnostic companies and academic tech transfer offices will make ... business leaders, angel, private equity, and venture capital investors, ...
Cached Medicine Technology:Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 2Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 3Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 4Consumer Reports Poll: 48 Percent of Americans on Meds Making Risky Health Care Tradeoffs 5Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C. 2Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C. 3Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C. 4Update: Innovative Companies to Present at AdvaMed 2011: The MedTech Conference Today in Washington, D.C. 5
(Date:9/3/2015)... ... September 03, 2015 , ... Today, Splashtop announced availability ... as part of the LANDESK One Partner program. Splashtop remote desktop ... mobile user experience in remote access and control:, , ...
(Date:9/3/2015)... ... September 03, 2015 , ... Advice columnist, professional ... her debut book, “Stop Wasting Your Time Blaming Others for Your Life.” , ... guide to overcoming life’s obstacles by taking full responsibility for one’s life shares ...
(Date:9/3/2015)... ... September 03, 2015 , ... Girl’s Night Out to benefit Core Compassion Project ... 6205 Kate Road in Monroe, North Carolina. The event food will be ... function, Kate Clyde’s offers off-premise catering and event services from casual to elegant. They ...
(Date:9/3/2015)... ... September 03, 2015 , ... For ... in its Annual Inc. 5000 list of fastest-growing private companies in America. ... fraction of the nation's companies have demonstrated such remarkably consistent high growth, particularly ...
(Date:9/3/2015)... ... September 03, 2015 , ... ... healthcare providers, has been retained to lead a national chief executive officer ... executive search firms in the healthcare industry, B. E. Smith has recently placed ...
Breaking Medicine News(10 mins):Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 2Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 3Health News:Splashtop Partners with LANDESK to Deliver High Performance Remote Access and Remote Support to and from Mobile Devices and Chromebook 4Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 2Health News:Popular Advice Columnist Shares Her Path to Overcoming Personal Trials in Debut Book 3Health News:Girl’s Night Out, with Food From Kate Clyde's Catered Creations, to Benefit Core Compassion Project 2Health News:Inc. 5000 Includes Intellicure, Inc., Two Years in a Row 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 2Health News:Melissa Memorial Hospital Retains B. E. Smith to Recruit New CEO 3
... 2008 Elsevier and the Alzheimer,s ... Journal of the Alzheimer,s Association ( www.alzheimersanddementia.org ... MEDLINE (www.pubmed.gov) is the premier bibliographic database of ... the National Institutes of Health (NIH), MEDLINE contains ...
... The editors of Neurotherapeutics are pleased ... to "Novel Therapeutics for Alzheimer,s Disease." Neurotherapeutics ... American Society of Experimental NeuroTherapeutics (ASENT) www.asent.org ... Alzheimer,s Association International Conference on Alzheimer,s Disease (ICAD), ...
... 24 The Connecticut,Hospice, Inc., birthplace of Hospice ... six Nurse Scholars from The Henrietta Szold-Hadassah-Hebrew,University School ... University College of Nursing., Lauren Brown, MSN, ... of the Norma F. Pfriem International,Fellowship in Hospice ...
... exclusive brand, of home health care products, ... calling ... As consumerism, the,aging patient population and evolving government ... Cardinal Health today launched new,tools to help retail independent ...
... AHA-McKesson Quest for Quality Prize, ANN ARBOR, Mich., ... of the University of Michigan Health,System provide some of ... of the safest, too. That,s according to the American ... lone finalist,for a major annual award., U-M comes ...
... Horizon Therapeutics, Inc.,a privately held biopharmaceutical company, ... president, chief executive officer and member of the,board ... a long, proven track record of successfully commercializing,multi-billion ... said George,Tidmarsh, M.D., Ph.D., founder, scientific consultant and ...
Cached Medicine News:Health News:Alzheimer's & Dementia: The Journal of the Alzheimer's Association accepted for coverage in MEDLINE 2Health News:Neurotherapeutics presents special issue on new treatments for Alzheimer's disease 2Health News:Cardinal Health Expands Leader(R) Offering To Help Independent Pharmacies Strengthen Patient Relationships, Solidify Role As Local Health Care Experts 2Health News:Cardinal Health Expands Leader(R) Offering To Help Independent Pharmacies Strengthen Patient Relationships, Solidify Role As Local Health Care Experts 3Health News:Cardinal Health Expands Leader(R) Offering To Help Independent Pharmacies Strengthen Patient Relationships, Solidify Role As Local Health Care Experts 4Health News:Cardinal Health Expands Leader(R) Offering To Help Independent Pharmacies Strengthen Patient Relationships, Solidify Role As Local Health Care Experts 5Health News:U-M Health System Honored by American Hospital Association for High Quality Care and Patient Safety 2Health News:U-M Health System Honored by American Hospital Association for High Quality Care and Patient Safety 3Health News:U-M Health System Honored by American Hospital Association for High Quality Care and Patient Safety 4Health News:Horizon Therapeutics Names Timothy P. Walbert as President and CEO 2
Pkg qty: box of 2 bags pack of 25 (Pack = Zippered Bag)...
... Applied Biosystems has developed a comprehensive ... when using sequence detection systems (SDS) ... simple and easy to follow. Many ... concentration and the thermal cycling protocol ...
... to seal the ABI PRISM Optical 384-Well ... Systems only, not compatible with Sequence Detection ... With:, Dual 384-Well, GeneAmp PCR System 9700, ... Plate with Barcode (code 128), Auto-Lid Dual ...
... Applied Biosystems has developed a comprehensive ... when using sequence detection systems (SDS) ... simple and easy to follow. Many ... concentration and the thermal cycling protocol ...
Medicine Products: